Gritstone Bio Inc (GRTS)

Gritstone Bio Inc Borsa (GRTS) Ultime notizie

Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock

Benzinga

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks Investment Research

Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings

Zacks Investment Research

Should SNDL (SNDL) be in Your Portfolio Ahead of Q1 Earnings?

Zacks Investment Research

Should You Buy Hims & Hers Health (HIMS) Ahead of Q1 Earnings?

Zacks Investment Research

Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings

Zacks Investment Research

Down -63.39% in 4 Weeks, Here's Why Gritstone bio (GRTS) Looks Ripe for a Turnaround

Zacks Investment Research

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering

Seeking Alpha

Gritstone (GRTS) Plummets 58% in a Week: Here's Why

Zacks Investment Research

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher

Benzinga

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Crude Oil Surges Over 1%; US Factory Orders Increase In February

Benzinga

Dow Dips Over 400 Points; Paychex Posts Downbeat Sales

Benzinga

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Benzinga

Paychex, PVH And 3 Stocks To Watch Heading Into Tuesday

Benzinga

Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering

GlobeNewswire Inc.

Gritstone bio Announces Proposed Public Offering

GlobeNewswire Inc.

Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

GlobeNewswire Inc.

Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?

Zacks Investment Research

Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

GlobeNewswire Inc.

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Benzinga

C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research

Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

GlobeNewswire Inc.

Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial

GlobeNewswire Inc.

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Gritstone bio to Participate in Upcoming Investor Conference

GlobeNewswire Inc.

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

MarketWatch

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

MarketWatch

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.